Literature DB >> 28387450

Severe demyelination in a patient with a late infantile form of Niemann-Pick disease type C.

Tsuyoshi Kodachi1, Shizuko Matsumoto1, Masashi Mizuguchi2, Hitoshi Osaka1, Nobuyuki Kanai3, Eiji Nanba4, Kousaku Ohno5, Takanori Yamagata2.   

Abstract

Niemann-Pick disease type C (NPC) is a cholesterol storage disease caused by defective cellular cholesterol transportation. The onset and progression of NPC are variable, and autopsy findings have mainly been reported for the adult and juvenile forms of this disease. Here we report the clinical and pathological findings from a 9-year-old female patient with the late infantile form of NPC due to NPC1 gene mutation. She had notable splenomegaly at 4 months of age. She lost the ability to speak at 18 months of age. She learned to walk, but often fell and could no longer walk after 30 months. At 3 years of age, she was diagnosed with NPC. Sequence analysis of the NPC1 gene revealed compound heterozygous mutation of T2108C (F703S) and C2348G (S813X) (both novel). Thereafter, the patient suffered repeated respiratory infections and died of respiratory failure at 9 years of age. Pathological findings included cerebral atrophy (particularly of white matter), severe demyelination, and the loss of neurons from the cerebrum and from the nuclei of the brain stem. Remnant neuronal cells and microglia in the cerebrum, cerebellum, and brain stem had become swollen and foamy. Neurons of the hippocampal CA1 and Purkinje cells were relatively spared, and senile plaques and axonal spheroids were not present. Foamy cells were also observed in other organs, especially the spleen and bone marrow. The F703S mutation in this patient was localized in a sterol-sensing domain (SSD). Severe neurological phenotypes have been previously reported in patients with missense mutations in an SSD. It is considered that the combination of a nonsense mutation and missense mutation in an SSD was responsible for the severe neurological phenotype of our present patient. While pathological findings of adult/juvenile forms of NPC have included swollen neurons and glia, neuronal cell loss, and NFTs, demyelination may be a predominant finding in the infantile form of NPC.
© 2017 Japanese Society of Neuropathology.

Entities:  

Keywords:  Niemann-Pick disease type C (NPC); autopsy; demyelination; late infantile form; severe infantile form

Mesh:

Year:  2017        PMID: 28387450     DOI: 10.1111/neup.12380

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  10 in total

1.  Mass spectrometry imaging of lipids: untargeted consensus spectra reveal spatial distributions in Niemann-Pick disease type C1.

Authors:  Fernando Tobias; Matthew T Olson; Stephanie M Cologna
Journal:  J Lipid Res       Date:  2018-09-28       Impact factor: 5.922

2.  The CD22-IGF2R interaction is a therapeutic target for microglial lysosome dysfunction in Niemann-Pick type C.

Authors:  John V Pluvinage; Jerry Sun; Christel Claes; Ryan A Flynn; Michael S Haney; Tal Iram; Xiangling Meng; Rachel Lindemann; Nicholas M Riley; Emma Danhash; Jean Paul Chadarevian; Emma Tapp; David Gate; Sravani Kondapavulur; Inma Cobos; Sundari Chetty; Anca M Pașca; Sergiu P Pașca; Elizabeth Berry-Kravis; Carolyn R Bertozzi; Mathew Blurton-Jones; Tony Wyss-Coray
Journal:  Sci Transl Med       Date:  2021-12-01       Impact factor: 19.319

3.  Clinical manifestations and gene analysis of Hutchinson-Gilford progeria syndrome: A case report.

Authors:  Su-Li Zhang; Shuang-Zhu Lin; Yan-Qiu Zhou; Wan-Qi Wang; Jia-Yi Li; Cui Wang; Qi-Ming Pang
Journal:  World J Clin Cases       Date:  2022-05-26       Impact factor: 1.534

4.  Mass spectrometry imaging and LC/MS reveal decreased cerebellar phosphoinositides in Niemann-Pick type C1-null mice.

Authors:  Koralege C Pathmasiri; Melissa R Pergande; Fernando Tobias; Rima Rebiai; Avia Rosenhouse-Dantsker; Ernesto R Bongarzone; Stephanie M Cologna
Journal:  J Lipid Res       Date:  2020-05-05       Impact factor: 5.922

5.  Gene Therapy in a Mouse Model of Niemann-Pick Disease Type C1.

Authors:  Yoshie Kurokawa; Hitoshi Osaka; Takeshi Kouga; Eriko Jimbo; Kazuhiro Muramatsu; Sachie Nakamura; Yuki Takayanagi; Tatsushi Onaka; Shin-Ichi Muramatsu; Takanori Yamagata
Journal:  Hum Gene Ther       Date:  2021-02-22       Impact factor: 5.695

Review 6.  Oligodendrocyte precursor cell maturation: role of adenosine receptors.

Authors:  Federica Cherchi; Anna Maria Pugliese; Elisabetta Coppi
Journal:  Neural Regen Res       Date:  2021-09       Impact factor: 5.135

Review 7.  Clinical and Molecular Features of Early Infantile Niemann Pick Type C Disease.

Authors:  Berna Seker Yilmaz; Julien Baruteau; Ahad A Rahim; Paul Gissen
Journal:  Int J Mol Sci       Date:  2020-07-17       Impact factor: 5.923

8.  Modeling Niemann-Pick disease type C1 in zebrafish: a robust platform for in vivo screening of candidate therapeutic compounds.

Authors:  Wei-Chia Tseng; Hannah E Loeb; Wuhong Pei; Chon-Hwa Tsai-Morris; Lisha Xu; Celine V Cluzeau; Christopher A Wassif; Benjamin Feldman; Shawn M Burgess; William J Pavan; Forbes D Porter
Journal:  Dis Model Mech       Date:  2018-08-15       Impact factor: 5.758

9.  Lipid-induced lysosomal damage after demyelination corrupts microglia protective function in lysosomal storage disorders.

Authors:  Enrique Gabandé-Rodríguez; Azucena Pérez-Cañamás; Beatriz Soto-Huelin; Daniel N Mitroi; Sara Sánchez-Redondo; Elena Martínez-Sáez; César Venero; Héctor Peinado; María Dolores Ledesma
Journal:  EMBO J       Date:  2018-12-07       Impact factor: 11.598

10.  Adenosine A2A receptor stimulation restores cell functions and differentiation in Niemann-Pick type C-like oligodendrocytes.

Authors:  Chiara De Nuccio; Antonietta Bernardo; Antonella Ferrante; Rita Pepponi; Alberto Martire; Mario Falchi; Sergio Visentin; Patrizia Popoli; Luisa Minghetti
Journal:  Sci Rep       Date:  2019-07-05       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.